Literature DB >> 4074130

Distribution of 3H-soman in mice.

T Kadar, L Raveh, G Cohen, N Oz, I Baranes, A Balan, Y Ashani, S Shapira.   

Abstract

3H-soman (specific activity 10 Ci/mMol), a potent irreversible cholinesterase inhibitor, was administered IV to mice in a dose of one LD-50, which corresponds to 0.25 mCi/mouse. Animals were sacrificed at 5 min, 2 h and 24 h, and whole body autoradiography was performed. High levels of radioactivity in lung and skin were observed at all time intervals after injection. The central nervous system showed very low concentrations of radioactivity, which remained so for 24 h post-injection. Considerable accumulation of 3H-soman in the urine and gall-bladder, and in the intestinal lumen, may indicate these as pathways of soman excretion. Quantitative determinations of radioactivity in various tissue samples were consistent with the above-mentioned findings. It is concluded that the nature of the persistent binding of soman to lung and skin is striking, and may indicate the existence of specific sites for soman depots.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4074130     DOI: 10.1007/BF00292616

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  15 in total

1.  The influence of oximes on the distribution of 32P in the body of the rat after injection of 32P-sarin.

Authors:  R L Polak; E M Cohen
Journal:  Biochem Pharmacol       Date:  1970-03       Impact factor: 5.858

2.  Problems in the therapy of Soman poisoning.

Authors:  O L Wolthuis; F Berends; E Meeter
Journal:  Fundam Appl Toxicol       Date:  1981 Mar-Apr

Review 3.  Anomalies in theories and therapy of intoxication by potent organophosphorus anticholinesterase compounds.

Authors:  R I Ellin
Journal:  Gen Pharmacol       Date:  1982

4.  The protection of animals against organophosphate poisoning by pretreatment with a carbamate.

Authors:  J J Gordon; L Leadbeater; M P Maidment
Journal:  Toxicol Appl Pharmacol       Date:  1978-01       Impact factor: 4.219

5.  Persistence of the anti-cholinesterase soman in rats; antagonism with a non-toxic simulator of this organophosphate.

Authors:  O L Wolthuis; H P Benschop; F Berends
Journal:  Eur J Pharmacol       Date:  1981-01-29       Impact factor: 4.432

6.  Distribution of DF32P in mouse organs. I. The effect of route of administration of incorporation and toxicity.

Authors:  B V Ramachandran
Journal:  Biochem Pharmacol       Date:  1966-02       Impact factor: 5.858

7.  Correlation between cholinesterase inhibition and reduction in muscarinic receptors and choline uptake by repeated diisopropylfluorophosphate administration: antagonism by physostigmine and atropine.

Authors:  S Yamada; M Isogai; H Okudaira; E Hayashi
Journal:  J Pharmacol Exp Ther       Date:  1983-08       Impact factor: 4.030

8.  Toxicity of soman after repetitive injection of sublethal doses in guinea-pig and mouse.

Authors:  S H Sterri; S Lyngaas; F Fonnum
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1981-07

9.  Serum level and excretion of diisopropylfluorophosphate (DFP) in cats.

Authors:  D Hansen; E Schaum; O Wassermann
Journal:  Biochem Pharmacol       Date:  1968-07       Impact factor: 5.858

10.  The treatment of Soman poisoning and its perspectives.

Authors:  B Bosković
Journal:  Fundam Appl Toxicol       Date:  1981 Mar-Apr
View more
  4 in total

1.  Poisoning with Soman, an Organophosphorus Nerve Agent, Alters Fecal Bacterial Biota and Urine Metabolites: a Case for Novel Signatures for Asymptomatic Nerve Agent Exposure.

Authors:  Derese Getnet; Aarti Gautam; Raina Kumar; Allison Hoke; Amrita K Cheema; Franco Rossetti; Caroline R Schultz; Rasha Hammamieh; Lucille A Lumley; Marti Jett
Journal:  Appl Environ Microbiol       Date:  2018-10-17       Impact factor: 4.792

2.  Effects of CBDP and MEPQ on the toxicity and distribution of [3H]-soman in mice.

Authors:  S Shapira; T Kadar; G Cohen; S Chapman; L Raveh
Journal:  Arch Toxicol       Date:  1990       Impact factor: 5.153

3.  Long-Term Anxiety-like Behavior and Microbiota Changes Induced in Mice by Sublethal Doses of Acute Sarin Surrogate Exposure.

Authors:  Sabine François; Stanislas Mondot; Quentin Gerard; Rosalie Bel; Julie Knoertzer; Asma Berriche; Sophie Cavallero; Rachid Baati; Cyrille Orset; Gregory Dal Bo; Karine Thibault
Journal:  Biomedicines       Date:  2022-05-18

Review 4.  Naturally Occurring Genetic Variants of Human Acetylcholinesterase and Butyrylcholinesterase and Their Potential Impact on the Risk of Toxicity from Cholinesterase Inhibitors.

Authors:  Oksana Lockridge; Robert B Norgren; Rudolph C Johnson; Thomas A Blake
Journal:  Chem Res Toxicol       Date:  2016-08-31       Impact factor: 3.739

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.